Hennink WE - Search Results

1

Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells.

Dolman ME, Harmsen S, Storm G, Hennink WE, Kok RJ. Dolman ME, et al. Among authors: hennink we. Adv Drug Deliv Rev. 2010 Nov 30;62(14):1344-57. doi: 10.1016/j.addr.2010.07.011. Epub 2010 Aug 16. Adv Drug Deliv Rev. 2010. PMID: 20719242 Review.

2

Comparative transfection studies of human ovarian carcinoma cells in vitro, ex vivo and in vivo with poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes.

van de Wetering P, Schuurmans-Nieuwenbroek NM, Hennink WE, Storm G. van de Wetering P, et al. Among authors: hennink we. J Gene Med. 1999 May-Jun;1(3):156-65. doi: 10.1002/(SICI)1521-2254(199905/06)1:3<156::AID-JGM29>3.0.CO;2-O. J Gene Med. 1999. PMID: 10738564

3

Cationic polymeric gene delivery of beta-glucuronidase for doxorubicin prodrug therapy.

Fonseca MJ, Storm G, Hennink WE, Gerritsen WR, Haisma HJ. Fonseca MJ, et al. Among authors: hennink we. J Gene Med. 1999 Nov-Dec;1(6):407-14. doi: 10.1002/(SICI)1521-2254(199911/12)1:6<407::AID-JGM71>3.0.CO;2-Q. J Gene Med. 1999. PMID: 10753066

4

Effects of physicochemical characteristics of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes on cellular association and internalization.

Zuidam NJ, Posthuma G, de Vries ET, Crommelin DJ, Hennink WE, Storm G. Zuidam NJ, et al. Among authors: hennink we. J Drug Target. 2000;8(1):51-66. doi: 10.3109/10611860009009209. J Drug Target. 2000. PMID: 10761645

5

The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration.

Verbaan FJ, Oussoren C, van Dam IM, Takakura Y, Hashida M, Crommelin DJ, Hennink WE, Storm G. Verbaan FJ, et al. Among authors: hennink we. Int J Pharm. 2001 Feb 19;214(1-2):99-101. doi: 10.1016/s0378-5173(00)00642-6. Int J Pharm. 2001. PMID: 11282245

6

Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells.

Mastrobattista E, Kapel RH, Eggenhuisen MH, Roholl PJ, Crommelin DJ, Hennink WE, Storm G. Mastrobattista E, et al. Among authors: hennink we. Cancer Gene Ther. 2001 Jun;8(6):405-13. doi: 10.1038/sj.cgt.7700311. Cancer Gene Ther. 2001. PMID: 11498760

7

Novel crosslinking methods to design hydrogels.

Hennink WE, van Nostrum CF. Hennink WE, et al. Adv Drug Deliv Rev. 2002 Jan 17;54(1):13-36. doi: 10.1016/s0169-409x(01)00240-x. Adv Drug Deliv Rev. 2002. PMID: 11755704 Review.

8

Nanotechnological approaches for the delivery of macromolecules.

Crommelin DJ, Storm G, Jiskoot W, Stenekes R, Mastrobattista E, Hennink WE. Crommelin DJ, et al. Among authors: hennink we. J Control Release. 2003 Feb 21;87(1-3):81-8. doi: 10.1016/s0168-3659(03)00014-2. J Control Release. 2003. PMID: 12618025 Review.

9

Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes.

van Steenis JH, van Maarseveen EM, Verbaan FJ, Verrijk R, Crommelin DJ, Storm G, Hennink WE. van Steenis JH, et al. Among authors: hennink we. J Control Release. 2003 Feb 21;87(1-3):167-76. doi: 10.1016/s0168-3659(02)00361-9. J Control Release. 2003. PMID: 12618033

10

Shifting paradigms: biopharmaceuticals versus low molecular weight drugs.

Crommelin DJ, Storm G, Verrijk R, de Leede L, Jiskoot W, Hennink WE. Crommelin DJ, et al. Among authors: hennink we. Int J Pharm. 2003 Nov 6;266(1-2):3-16. doi: 10.1016/s0378-5173(03)00376-4. Int J Pharm. 2003. PMID: 14559389 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

568 results

Search Page

Filters